NORTHWEST BIOTHERAPEUTICS INC Loss Contingency Accrual
NORTHWEST BIOTHERAPEUTICS INC (NWBO) had Loss Contingency Accrual of $900.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Commitment and Contingencies › Loss Contingency Accrual, Disclosures
us-gaap:LossContingencyAccrualAtCarryingValue · last filed 2026-08-14
- 2023-12-31: Loss Contingency Accrual 188.00K EUR.
- 2023-09-30: Loss Contingency Accrual 377.00K EUR.
- 2023-06-30: Loss Contingency Accrual 377.00K EUR.
- 2023-03-31: Loss Contingency Accrual 377.00K EUR.
EUR
| Period end | Loss Contingency Accrual |
|---|---|
| 2023-12-31 | 188.00K EUR 10-K · filed 2024-03-05 |
| 2023-09-30 | 377.00K EUR 10-Q · filed 2023-11-09 |
| 2023-06-30 | 377.00K EUR 10-Q · filed 2023-08-09 |
| 2023-03-31 | 377.00K EUR 10-Q · filed 2023-05-10 |
| 2022-12-31 | 377.00K EUR 10-K · filed 2023-02-28 |
| 2022-09-30 | 377.00K EUR 10-Q · filed 2022-11-09 |
| 2022-06-30 | 370.00K EUR 10-Q · filed 2022-08-09 |
| 2021-06-30 | 120.00K EUR 10-Q · filed 2021-08-16 |
USD
| Period end | Loss Contingency Accrual |
|---|---|
| 2026-06-30 | $900.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.20M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $1.60M 10-K · filed 2026-04-15 |
| 2025-07-30 | $1.00M 10-K · filed 2026-04-15 |
| 2023-12-31 | $207.00K 10-K · filed 2024-03-05 |
| 2023-09-30 | $399.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $410.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $410.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $403.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $369.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $386.00K 10-Q · filed 2022-08-09 |
| 2021-06-30 | $143.00K 10-Q · filed 2021-08-16 |